1-13 of 13
Mark A. Dickson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B010: Response to treatment with nab-sirolimus among patients with primary uterine tumors: A subgroup analysis from AMPECT

Vinod Ravi, Mark A. Dickson, Kristin Ganjoo, Li Ding, Anita N. Schmid, Norma A. Palma, Willis H. Navarro, Andrew J. Wagner
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (5_Supplement): B010.
https://doi.org/10.1158/1557-3265.ENDO24-B010
Published: 01 March 2024
View article titled, Abstract B010: Response to treatment with <em>nab</em>-sirolimus among patients with primary uterine tumors: A subgroup analysis from AMPECT
Journal Articles

Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Caroline E. Gleason, Mark A. Dickson, Mary E. Klein (Dooley), Cristina R. Antonescu, Rodrigo Gularte-Mérida, Marimar Benitez, Juliana I. Delgado, Raghu P. Kataru, Mark Wei Yi Tan, Martina Bradic, Travis E. Adamson, Kenneth Seier, Allison L. Richards, Marta Palafox, Eric Chan, Sandra P. D'Angelo, Mrinal M. Gounder, Mary Louise Keohan, Ciara M. Kelly, Ping Chi, Sujana Movva, Jonathan Landa, Aimee M. Crago, Mark T.A. Donoghue, Li-Xuan Qin, Violetta Serra, Mesruh Turkekul, Afsar Barlas, Daniel M. Firester, Katia Manova-Todorova, Babak J. Mehrara, Marta Kovatcheva, Nguan Soon Tan, Samuel Singer, William D. Tap, Andrew Koff
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (4): 703–718.
https://doi.org/10.1158/1078-0432.CCR-23-2378
Published: 16 February 2024
View article titled, Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma
Open the PDF for Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma in another window
Includes: Supplementary data
Journal Articles

A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma

Ciara M. Kelly, Li-Xuan Qin, Karissa A. Whiting, Allison L. Richards, Viswatej Avutu, Jason E. Chan, Ping Chi, Mark A. Dickson, Mrinal M. Gounder, Mary Louise Keohan, Sujana Movva, Benjamin A. Nacev, Evan Rosenbaum, Travis Adamson, Samuel Singer, Edmund K. Bartlett, Aimee M. Crago, Sam S. Yoon, Sinchun Hwang, Joseph P. Erinjeri, Cristina R. Antonescu, William D. Tap, Sandra P. D'Angelo
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (11): 2043–2051.
https://doi.org/10.1158/1078-0432.CCR-22-3911
Published: 01 June 2023
View article titled, A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma
Open the PDF for A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma in another window
Includes: Supplementary data
Journal Articles

A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma

Mrinal M. Gounder, Evan Rosenbaum, Nian Wu, Mark A. Dickson, Tahir N. Sheikh, Sandra P. D'Angelo, Ping Chi, Mary Lou Keohan, Joseph P. Erinjeri, Cristina R. Antonescu, Narasimhan Agaram, Meera R. Hameed, Moriah Martindale, Robert A. Lefkowitz, Aimee M. Crago, Sam Singer, William D. Tap, Naoko Takebe, Li-Xuan Qin, Gary K. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1586–1594.
https://doi.org/10.1158/1078-0432.CCR-21-3874
Published: 14 April 2022
View article titled, A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma
Open the PDF for A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma in another window
Includes: Supplementary data
Journal Articles

Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors

Ping Chi, Li-Xuan Qin, Niedzica Camacho, Ciara M. Kelly, Sandra P. D'Angelo, Mark A. Dickson, Mrinal M. Gounder, Mary L. Keohan, Sujana Movva, Benjamin A. Nacev, Evan Rosenbaum, Katherine A. Thornton, Aimee M. Crago, Jasmine H. Francis, Moriah Martindale, Haley T. Phelan, Matthew D. Biniakewitz, Cindy J. Lee, Samuel Singer, Sinchun Hwang, Michael F. Berger, Yu Chen, Cristina R. Antonescu, William D. Tap
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1507–1517.
https://doi.org/10.1158/1078-0432.CCR-21-3909
Published: 14 April 2022
View article titled, Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors
Open the PDF for Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors in another window
Includes: Supplementary data
Journal Articles

Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma

Nicholas D. Klemen, Sinchun Hwang, Martina Bradic, Evan Rosenbaum, Mark A. Dickson, Mrinal M. Gounder, Ciara M. Kelly, Mary L. Keohan, Sujana Movva, Katherine A. Thornton, Ping Chi, Benjamin A. Nacev, Jason E. Chan, Edmund K. Bartlett, Allison L. Richards, Samuel Singer, Mark T.A. Donoghue, William D. Tap, Sandra P. D'Angelo
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 939–947.
https://doi.org/10.1158/1078-0432.CCR-21-3445
Published: 01 March 2022
View article titled, Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Open the PDF for Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma in another window
Includes: Supplementary data
Journal Articles

A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma

Christina V. Angeles, Ana Velez, Jordan Rios, Bernadette Laxa, David Shum, Penelope D. Ruiz, Yawei Shen, Irina Ostrovnaya, Rodrigo Gularte-Mérida, Benjamin A. Nacev, Mark A. Dickson, Hakim Djaballah, Tomoyo Okada, Samuel Singer
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (1): 175–186.
https://doi.org/10.1158/1078-0432.CCR-19-2486
Published: 05 January 2022
View article titled, A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma
Open the PDF for A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma in another window
Includes: Supplementary data
Journal Articles

Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma

Erin G. Reid, Adrienne Suazo, Shelly Y. Lensing, Dirk P. Dittmer, Richard F. Ambinder, Frank Maldarelli, Robert J. Gorelick, David Aboulafia, Ronald Mitsuyasu, Mark A. Dickson, William Wachsman
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (3): 558–565.
https://doi.org/10.1158/1078-0432.CCR-19-1044
Published: 03 February 2020
View article titled, Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma
Open the PDF for Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma in another window
Includes: Supplementary data
Journal Articles

Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab

Sandra P. D'Angelo, Alexander N. Shoushtari, Mary Louise Keohan, Mark A. Dickson, Mrinal M. Gounder, Ping Chi, Jennifer K. Loo, Leigh Gaffney, Lee Schneider, Zarine Patel, Joseph Patrick Erinjeri, Mark J. Bluth, Ana Sjoberg, Howard Streicher, Naoko Takebe, Li-Xuan Qin, Cristina Antonescu, Ronald P. DeMatteo, Richard D. Carvajal, William D. Tap
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (12): 2972–2980.
https://doi.org/10.1158/1078-0432.CCR-16-2349
Published: 14 June 2017
View article titled, Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab
Open the PDF for Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab in another window
Includes: Supplementary data
Journal Articles

Molecular Pathways: CDK4 Inhibitors for Cancer Therapy

Mark A. Dickson
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (13): 3379–3383.
https://doi.org/10.1158/1078-0432.CCR-13-1551
Published: 30 June 2014
View article titled, Molecular Pathways: CDK4 Inhibitors for Cancer Therapy
Open the PDF for Molecular Pathways: CDK4 Inhibitors for Cancer Therapy in another window
Journal Articles

The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates Doxorubicin Efficacy in Advanced Sarcomas: Preclinical Investigations and Results of a Phase I Dose-Escalation Clinical Trial

Jason J. Luke, David R. D'Adamo, Mark A. Dickson, Mary Louise Keohan, Richard D. Carvajal, Robert G. Maki, Elisa de Stanchina, Elgilda Musi, Samuel Singer, Gary K. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (9): 2638–2647.
https://doi.org/10.1158/1078-0432.CCR-11-3203
Published: 30 April 2012
View article titled, The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates Doxorubicin Efficacy in Advanced Sarcomas: Preclinical Investigations and Results of a Phase I Dose-Escalation Clinical Trial
Open the PDF for The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates Doxorubicin Efficacy in Advanced Sarcomas: Preclinical Investigations and Results of a Phase I Dose-Escalation Clinical Trial in another window
Includes: Supplementary data
Journal Articles

A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors

Mark A. Dickson, Richard D. Carvajal, Alfred H Merrill, Jr, Mithat Gonen, Lauren M. Cane, Gary K. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2484–2492.
https://doi.org/10.1158/1078-0432.CCR-10-2323
Published: 14 April 2011
View article titled, A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors
Open the PDF for A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors in another window
Journal Articles

Phase I Study of Flavopiridol with Oxaliplatin and Fluorouracil/Leucovorin in Advanced Solid Tumors

Dana Rathkopf, Mark A. Dickson, Darren R. Feldman, Richard D. Carvajal, Manish A. Shah, Nian Wu, Robert Lefkowitz, Mithat Gonen, Lauren M. Cane, Heather J. Dials, Jennifer L. Winkelmann, George J. Bosl, Gary K. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7405–7411.
https://doi.org/10.1158/1078-0432.CCR-09-1502
Published: 30 November 2009
View article titled, Phase I Study of Flavopiridol with Oxaliplatin and Fluorouracil/Leucovorin in Advanced Solid Tumors
Open the PDF for Phase I Study of Flavopiridol with Oxaliplatin and Fluorouracil/Leucovorin in Advanced Solid Tumors in another window